prednimustine has been researched along with B-Cell Chronic Lymphocytic Leukemia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arcicasa, M; Bortolus, R; Carbone, A; De Paoli, A; Franchin, G; Pinto, A; Roncadin, M; Trovò, MG; Valeri, P; Zagonel, V | 1 |
| Freund, M; Hanauske, AR; Hiddemann, W; Link, H; Poliwoda, H; Schäfers, M; Schmoll, HJ; Seidel, I; Wunsch-Zeddies, S; Wysk, J | 1 |
1 trial(s) available for prednimustine and B-Cell Chronic Lymphocytic Leukemia
| Article | Year |
|---|---|
Total body irradiation and prednimustine in chronic lymphocytic leukemia and low grade non-Hodgkin's lymphomas. A 9-year experience at a single institution.
Topics: Age Factors; Aged; Aged, 80 and over; Combined Modality Therapy; Drug Administration Schedule; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, Non-Hodgkin; Middle Aged; Prednimustine; Radiotherapy Dosage; Treatment Outcome; Whole-Body Irradiation | 1994 |
1 other study(ies) available for prednimustine and B-Cell Chronic Lymphocytic Leukemia
| Article | Year |
|---|---|
Prednimustine and mitoxantrone (PmM) in patients with low-grade malignant non-Hodgkin's lymphoma (NHL), chronic lymphocytic leukemia (CLL), and prolymphocytic leukemia (PLL).
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Female; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Promyelocytic, Acute; Lymphoma, Non-Hodgkin; Male; Middle Aged; Mitoxantrone; Prednimustine | 1992 |